Fremont, California, Düsseldorf – May 7, 2025 – Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), today announced it has licensed ATUM’s proprietary Leap-In Transposase® transposon-based gene delivery and its miCHO™ cell line development technologies.

Optimizing charge and discharge of rechargeable batteries in remote controls, IoT sensors, Bluetooth® trackers, etc.

Asahi Kasei, Nobian, Furuya Metal, and Mastermelt commenced joint project to recycle metals from electrolyzer components – signaling a major milestone towards circularity in the chlor-alkali industry

Asahi Kasei to present easy-to-process particle foam for composite foam core applications at JEC World 2025

Car users’ concerns to define interior of fully autonomous cars, citing 5th Global Automotive Consumer Survey by Asahi Kasei

Asahi Kasei receives 2024 TSMC Excellent Performance Award in recognition of its Pimel™ photosensitive dielectric for advanced semiconductor packaging

Jiangsu Sailboat Petrochemical started a new carbonates plant using Asahi Kasei’s production technology for CO2-based ethylene carbonate and dimethyl carbonate.

Asahi Kasei Microdevices Advances AgeTech with Better AI-Ready Data Through New Sensor Technologies – Devices will be demonstrated at CES 2025, showing how aging in place can be safer and more accessible

Asahi Kasei and Honda Sign Shareholders’ Agreement to Convert Existing Asahi Kasei Subsidiary into Joint Venture for Production of Lithium-ion Battery Separators in Canada

Asahi Kasei Medical launches Planova™ FG1 next-generation virus removal filter

Asahi Kasei and Aquafil collaborate on cellulose nanofiber and regenerated ECONYL® Polymer for 3D printing applications

Asahi Kasei launches new grade of LASTAN™ flame-retardant nonwoven fabric

Asahi Kasei enters collaboration with De Nora for development and sale of small-scale containerized electrolyzers for hydrogen production

Asahi Kasei Engineering launches cloud-based CAE solution platform

Asahi Kasei to showcase material solutions for thermal management of EVs, recycling and 3D printing at Fakuma 2024

Gas Sensor for Highly Flammable Refrigerant (R290) Ensures Safe and Accurate Refrigerant Leak Detection in HVAC Systems

Asahi Kasei Engineering to introduce cloud-based predictive maintenance service V-MO for monitoring of ocean vessel motors at SMM 2024

Asahi Kasei’s newest global car user survey gives insights into the brand loyalty and buying behavior of car users in the four major automotive markets.

Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI (water for injection), a type of sterile water that is used for the preparation of injections.

Crystal IS, an Asahi Kasei company, today announced the successful serial production of 100 mm diameter single-crystal aluminum nitride (AlN) substrates with 99% usable area, based on current requirements for UVC LEDs.

The Japanese technology company Asahi Kasei has successfully achieved proof of concept (POC) of lithium-ion batteries (LIBs) using its proprietary high ionic conductive electrolyte.

At the DKT 2024, Asahi Kasei will present its newly developed hydrogenated solution styrene butadiene rubber (HSBR).

Asahi Kasei Microdevices achieves successful Proof of Concept for eFuse in high voltage 800 V automotive applications – Door opener for compact, fast and reliable protection of on-board chargers or DC/DC converters for electric vehicles.

Bionova Scientific, an Asahi Kasei Group company and full-service biologics CDMO, announced plans to invest $100 million to expand into plasmid DNA (pDNA) production.

Asahi Kasei Corp. today announces that it will offer the shareholders of Calliditas Therapeutics AB to acquire the shares of the pharmaceutical company Calliditas for the purpose of making Calliditas a wholly-owned subsidiary of Asahi Kasei (“the Acquisition”) through a voluntary tender offer for Calliditas (“the Tender Offer”).

Asahi Kasei Medical has completed the construction of its third assembly plant for Planova™ virus removal filters in Nobeoka, Miyazaki, Japan, and held its completion ceremony on May 24, 2024.

On May 13, company representatives and partners including the Japanese government celebrated the official opening of a new hydrogen pilot plant in Kawasaki, Japan.

Asahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA – Offering reduced changeover time while maintaining safety and product quality.

Asahi Kasei announced today that it will construct an integrated plant in Ontario, Canada for the base film manufacturing and coating of Hipore™ wet-process lithium-ion battery (LIB) separator.

Asahi Kasei Plastics North America (APNA) will highlight new technologies, such as its 3D printing filament, at the NPE 2024, the largest plastics industry trade show in the Americas, from May 6 through 10 in Orlando.

Asahi Kasei Bioprocess (AKB) and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.

AW Technologies and Asahi Kasei Medical, a core operating company of the Japanese technology company Asahi Kasei, have entered into an exclusive distribution agreement in Japan for AW Technologies’ TrachFlush™ device.

Senseair, a subsidiary of Asahi Kasei Microdevices Corporation (AKM), has announced the launch of the Senseair S88.

Asahi Kasei Microdevices Corporation (AKM) has started mass production of the CZ39 series of coreless current sensors.

Asahi Kasei offers pharmaceutical excipient Ceolus™ with nitrite concentration of 0.1 ppm or less – Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals.

Asahi Kasei Europe joined Plastics Europe Germany, the leading association of plastics producers in Germany, in December 2023.

Asahi Kasei and an affiliated company have acquired the widely recognized international sustainability certification ISCC PLUS for several products.